Meeting Coverage


Society of Gynecologic Oncology

VTE Risk in Recurrent Ovarian Cancer Increases With More Lines of Chemotherapy

Prospective study in heavily treated population is warranted, researcher says

 SGO over a photo of the Tampa Convention Center in Tampa, Florida

Latest SGO Meeting Coverage

Obesity's Impact on Uterine Cancer Risk Greater in Younger Age Groups

Overall risk and risk of endometrioid subtype 20- to 30-fold greater in women younger than 35

March 30, 2023
Phase III Trials 'Hit a Home Run' in Advanced Endometrial Cancer

Adding immunotherapy will change frontline treatment, experts say

March 28, 2023
Novel Strategies Show Winning Potential in Ovarian Cancer

High response rates in small studies of immuno-oncology combination, neoadjuvant olaparib

March 28, 2023
No Survival Benefit With CRT Versus Chemo for Locally Advanced Endometrial Cancer

Long-running clinical trial failed to identify any subgroup that fared better with CRT

March 27, 2023
CRT Regimen Boosts Complete Response Rate in Unresectable Vulvar Cancer

Pathologic response rises to 73% versus 50% in historical control group

March 27, 2023
CDK4/6 Inhibition Active in Recurrent Low-Grade Serous Ovarian Cancer

Responses in a fourth of patients, clinical benefit in up to 90%

March 26, 2023
Intraperitoneal Carboplatin Boosts PFS in Ovarian Cancer

Should the gynecologic oncology community reconsider IP therapy?

March 22, 2022
It's Official: Minimally Invasive Hysterectomy Not Safer in Cervical Cancer

Final analysis of LACC trial confirms earlier findings

March 21, 2022
Lenvatinib Packaging for Endometrial Cancer Tied to $168 Million in Overspending

Presenter breaks news at SGO that drug developer commits to overhauling dose reduction program

March 20, 2022
Selinexor Proves Mettle in Advanced or Recurrent Endometrial Cancer

Benefit was greatest among patients with wild-type p53 cancer in SIENDO trial

March 20, 2022
Novel ADC Promising in Tough-to-Treat Ovarian Cancer

Ocular AEs an issue with mirvetuximab in folate receptor alpha-high platinum-resistant disease

March 20, 2022
Add-on Pembrolizumab Tied to Good QoL in Women With Advanced Cervical Cancer

PRO-based analysis of KEYNOTE-826 trial shows favorable benefit-risk ratio

March 19, 2022
Adjuvant Chemo Disappoints in Low-Grade Serous Ovarian Cancer

Study suggests no improvement in overall survival

March 19, 2022
Triage System Gets High Marks for Ovarian Cancer Debulking Surgery

Key factors predicted threefold higher risk of 90-day mortality with primary surgery

March 26, 2021


SGO Future Focus
April 2023
SGO Video Pearls
April 2023